TGA outcomes of listed sunscreen products review

0
Pharmacists may recall news headlines earlier this year about people experiencing significant sunburn despite application of high sun protection factor sunscreens. Reports were accompanied...

Systemic corticosteroids for dyspnoea

0
The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer. Dyspnoea affects almost 70% of advanced cancer patients at the...

Tips for extended telehealth consultations for medicines reviews

0
In response to the COVID-19 pandemic, pharmacists may continue delivering medicine reviews via telehealth until 31 March 2021.

2019 year in review

0
It was a big year for Australian pharmacists, with the release of important reports calling for reform for the profession and providing a vision...

Overprescribing of psychotropics for adults with autism

0
Adults on the autism spectrum are often prescribed psychotropic medication to manage behaviour, despite limited evidence to support this practice, a new report has...

How to get the most out of your PSA21 Virtual experience

0
There are just two days until PSA21 Virtual begins, with an exciting program of clinical, therapeutic and industry sessions for pharmacists in all practice settings.